Anticancer Drugs Olaparib Oncology Pharmacology Physiotherapy

Olaparib (Drug Interaction-7)

In this article we will discuss Olaparib (Drug Interaction-7). So, let’s get started.

Avoid concomitant use of strong CYP3A inducers such as phenytoin, rifampicin, carbamazepine, and St. John’s Wort or moderate CYP3A4 inducers such as bosentan, efavirenz, etravirine, modafinil, and nafcillin. If a moderate CYP3A inducer cannot be avoided, there is a potential for decreased efficacy of Olaparib.

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.